Profile data is unavailable for this security.
About the company
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd. are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants, and others. Its subsidiary, Karex Marketing Sdn. Bhd. engages in manufacturing and selling hand sanitizers, condoms, personal lubricants, and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd. are engaged in investment holding activity.
- Revenue in MYR (TTM)512.17m
- Net income in MYR-1.51m
- Incorporated2012
- Employees3.14k
- LocationKarex BhdLot 594Persiaran Raja LumuPandamaran Industrial EstateKLANG 42000MalaysiaMYS
- Phone+60 331656688
- Fax+60 331678070
- Websitehttps://www.karex.com.my/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FCW Holdings Bhd | 24.07m | 5.56m | 449.99m | 118.00 | 80.97 | 1.68 | -- | 18.70 | 0.0222 | 0.0222 | 0.0963 | 1.07 | 0.0614 | 4.36 | 3.16 | 203,983.00 | 0.8203 | -- | 0.8179 | -- | 15.56 | -- | 13.35 | -- | 60.90 | -- | 0.339 | -- | -7.97 | -- | -22.81 | -- | -- | -- |
| I-ne Co Ltd | 1.20bn | 61.56m | 482.60m | 434.00 | 7.78 | 1.08 | 4.64 | 0.4024 | 139.78 | 139.78 | 2,706.21 | 1,006.02 | 1.73 | 4.40 | 8.01 | 110,739,600.00 | 9.17 | 12.29 | 12.42 | 21.06 | 56.58 | 52.37 | 5.30 | 6.29 | 1.73 | 36.50 | 0.2685 | 4.18 | 8.08 | 16.24 | -25.70 | 50.23 | 49.49 | -- |
| Maxigen Biotech Inc | 98.60m | 29.12m | 491.50m | 96.00 | 16.93 | 2.68 | 14.98 | 4.98 | 2.60 | 2.60 | 8.81 | 16.43 | 0.4891 | 3.11 | 7.31 | -- | 14.45 | 9.87 | 16.62 | 11.15 | 69.33 | 61.07 | 29.54 | 22.47 | 3.84 | -- | 0.00 | 40.53 | 9.41 | 8.52 | 14.68 | 25.90 | 6.00 | 4.21 |
| Natural Beauty Bio-Technology Ltd | 231.66m | -31.24m | 502.60m | 525.00 | -- | 2.07 | -- | 2.17 | -0.0311 | -0.0311 | 0.2305 | 0.2421 | 0.5512 | 2.29 | 4.95 | 851,302.60 | -7.43 | -2.49 | -10.68 | -3.40 | 55.52 | 59.16 | -13.49 | -5.52 | 1.04 | -0.243 | 0.3144 | -- | 5.25 | -4.21 | -585.69 | -- | -11.62 | -- |
| Karex Bhd | 512.17m | -1.51m | 563.60m | 3.14k | -- | 1.24 | 19.30 | 1.10 | -0.0014 | -0.0014 | 0.4862 | 0.4316 | 0.6817 | 2.18 | 4.26 | 163,370.70 | -0.201 | 0.8049 | -0.2815 | 1.05 | 30.50 | 27.39 | -0.2948 | 1.18 | 0.672 | 1.48 | 0.3364 | 58.70 | -1.86 | 4.76 | -99.11 | -1.82 | 12.47 | 0.00 |
| Soft International Group Ltd | -50.21bn | -50.21bn | 572.36m | 326.00 | -- | 2.09 | -- | -- | -- | -- | -- | 0.5455 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.36 | -- | 0.1361 | -- | 15.01 | -- | -7.04 | -- | -- | -- |
| Anondita Medicare Ltd | 42.74m | 9.84m | 581.64m | -- | 59.10 | 12.49 | 55.65 | 13.61 | 12.69 | 12.69 | 55.11 | 60.06 | 0.8088 | 3.88 | 2.97 | -- | 18.99 | -- | 28.85 | -- | 53.29 | -- | 23.48 | -- | 2.46 | 10.41 | 0.2976 | -- | -- | -- | -- | -- | -- | -- |
| S & J International Enterprises PCL | 813.74m | 72.20m | 600.22m | 1.78k | 8.31 | 0.9687 | 5.02 | 0.7376 | 3.85 | 3.85 | 43.38 | 33.03 | 0.9097 | 4.03 | 5.58 | 3,648,086.00 | 9.28 | 8.40 | 12.29 | 10.70 | 30.16 | 29.72 | 10.20 | 9.01 | 2.08 | -- | 0.0507 | 48.88 | -9.49 | 5.93 | -33.62 | 13.01 | 9.20 | 6.40 |
| Holder | Shares | % Held |
|---|---|---|
| Abrdn Asia Ltd.as of 17 Jun 2025 | 63.87m | 6.06% |
| Abrdn Malaysia Sdn. Bhd.as of 26 Sep 2025 | 61.19m | 5.81% |
| Manulife Investment Management (M) Bhd.as of 26 Sep 2025 | 24.21m | 2.30% |
| Kumpulan Wang Persaraanas of 26 Sep 2025 | 23.63m | 2.24% |
| Great Eastern Life Assurance Co. Ltd.as of 26 Sep 2025 | 9.98m | 0.95% |
| Lion Global Investors Ltd.as of 30 Jun 2025 | 3.05m | 0.29% |
| Principal Asset Management Bhd.as of 30 Nov 2025 | 1.82m | 0.17% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 64.00k | 0.01% |
